REDWOOD CITY, CALIF.--(BUSINESS WIRE)--
Box, Inc. (NYSE:BOX), a leader in cloud content management, today announced Box GxP Validation, an innovative new approach for maintaining GxP compliance in the cloud. Box GxP Validation enables Pharmaceuticals, Biotechnology and Medical Device businesses to develop, validate and operate their GxP compliance standards within Box. Box GxP Validation methodology complies with GAMP5 guidelines, accelerates the validation process, and lowers risk via use of daily tests to assure a continued state of compliance for the Box cloud content management platform.
“As content increasingly becomes a more integral part of how life sciences organizations deliver the next generation of therapies to improve health and wellness, we’re excited to provide GxP Validation within Box so that customers can seamlessly manage both unregulated and regulated content in one centralized cloud content management platform,” said Riju Khetarpal, Managing Director, Box for Life Sciences. “With GxP Validation, companies in regulated industries can eliminate inefficient silos between regulated and unregulated information, and speed up collaboration and innovation.”
Box GxP Validation creates new opportunities for customers to build, manage, collaborate and distribute regulated content in Box as they work cross-functionally within their organization or with external business partners that are critical to the clinical development and drug manufacturing processes. Box GxP Validation provides businesses in the life sciences industry with a Validation Accelerator Pack (VAP) and daily reports to show that Box is functioning as intended to qualify and maintain compliance of their Box instance, so that they can:
As part of Box GxP Validation, Box is partnering with USDM, a leading risk management, technological innovation and business process optimization firm for the life sciences and healthcare industries, to provide Cloud Assurance, a new compliance maintenance methodology that continually tests all key functionality of the Box service prior to its release into production. Cloud Assurance validates changein the production environment to ensure that the change has not impacted the intended use of the service. USDM also works with clients directly to ensure their own configurations and customizations are unaffected by these changes on a case by case basis.
“At USDM, we specialize in risk management, compliance, and business process optimization for the life sciences industry,” said Kim Hutchings, Head of Alliances/Digital Transformation Lead at USDM Life Sciences. “We are excited to bring our industry expertise together with Box to enable heavily regulated life science businesses to fully transition to a cloud content management platform that supports both regulated and non-regulated content and create streamlined workflows that speed up innovation.”
Since announcing Box for Life Sciences in August of 2014, Box has seen continued momentum in the life sciences industry, with customers including: Eli Lily, AstraZeneca, Jazz Pharmaceuticals and Boston Scientific. Box for Life Sciences enables organizations across the globe to safeguard their most sensitive content, while securely collaborating between teams and partners, by providing the following capabilities and services:
Box (NYSE:BOX) is the cloud content management company that empowers enterprises to revolutionize how they work by securely connecting their people, information and applications. Founded in 2005, Box powers 80,000 businesses globally, including AstraZeneca, General Electric, P&G, and The GAP. Box is headquartered in Redwood City, CA, with offices across the United States, Europe and Asia. To learn more about Box, visit http://www.box.com.
Copyright Business Wire 2018